comparemela.com
Home
Live Updates
Cybin Pharmaceutical - Breaking News
Pages:
2
3
4
5
6
7
8
Latest Breaking News On - Cybin pharmaceutical - Page 1 : comparemela.com
Dagga firm Cilo Cybin prepares for clinical trials in SA as it again eyes JSE listing
Cilo Cybin Pharmaceutical may list on the JSE within months, while it is also planning to start clinical trials of cannabis-derived drugs before the end of 2023, in partnership with its new shareholder.
Cybin pharmaceutical
Cilo cybin
South African Pharmaceutical Market 2022: Pandemic Continues to Cause Business Interruptions and Supply Chain Challenges
/PRNewswire/ The "Pharmaceutical Industry in South Africa 2022" report has been added to ResearchAndMarkets.com s offering. The importance of the.
South africa
United states
Kwazulu natal
South african
Adcock ingram
Alpha pharm
Astellas pharma
Afrigen biologics
Aurobindo pharma
Eli lilly
Laura wood
Woolworths holdings
Vaccines institute of southern africa
Goodleaf company
Pickn pay stores
Pharmed pharmaceuticals
TAKE A LOOK | Inside Cilo Cybin, SA s first cannabis company to list on the JSE
It plans to have its cannabis oils and vapes on retailers’ shelves by December.
South africa
South african
Gabriel theron
Cilo cybin
Africa ntando thukwana
Business insider south
Ntando thukwana
Cybin pharmaceutical
Gauteng cannabis producer to become first to list on JSE, in 4-6 months
The Money Show finds out about Cilo Cybin Pharmaceutical's latest plans from CEO Gabriel Theron.
South africa
South african
Gabriel theron
Eric limon
Cilo cybin
University of technology
Johannesburg stock exchange
Money show
Cilo cybin pharmaceutical
Cybin pharmaceutical
Bloomberg news
Gauteng cannabis producer to become first to list on JSE, in 4-6 months
The Money Show finds out about Cilo Cybin Pharmaceutical's latest plans from CEO Gabriel Theron.
South africa
South african
Gabriel theron
Eric limon
Cilo cybin
University of technology
Johannesburg stock exchange
Money show
Cilo cybin pharmaceutical
Cybin pharmaceutical
Bloomberg news
vimarsana © 2020. All Rights Reserved.